Cargando…

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report

The authors present the case of a 24-year-old male with treatment-resistant schizophrenia, with predominant severe delusion and hallucination, who received bone marrow transplantation (BMT) for acute myeloid leukemia. After BMT, he showed a remarkable reduction in psychotic symptoms without administ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyaoka, Tsuyoshi, Wake, Rei, Hashioka, Sadayuki, Hayashida, Maiko, Oh-Nishi, Arata, Azis, Ilhamuddin Abdul, Izuhara, Muneto, Tsuchie, Keiko, Araki, Tomoko, Arauchi, Ryosuke, Abdullah, Rostia Arianna, Horiguchi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613125/ https://www.ncbi.nlm.nih.gov/pubmed/28983259 http://dx.doi.org/10.3389/fpsyt.2017.00174

Ejemplares similares

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report
por: Izuhara, Muneto, et al.
Publicado: (2018)

PS147. Gunn rats show depression-like behavior and microglial activation in the hippocampus
por: Arauchi, Ryosuke, et al.
Publicado: (2016)

Parvalbumin-positive GABAergic interneurons deficit in the hippocampus in Gunn rats: A possible hyperbilirubinemia-induced animal model of schizophrenia
por: Hayashida, Maiko, et al.
Publicado: (2019)

Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test
por: Arauchi, Ryosuke, et al.
Publicado: (2018)

Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat
por: Limoa, Erlyn, et al.
Publicado: (2016)

PM375. Electroconvulsive shock ameliorated the schizophrenia-like behavior and attenuated the glial activation in the hippocampus of Gunn Rat
por: Abdul Aziz, Erlyn Limoa Ilhamuddin, et al.
Publicado: (2016)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

Implications of Systemic Inflammation and Periodontitis for Major Depression
por: Hashioka, Sadayuki, et al.
Publicado: (2018)

The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms
por: Hashioka, Sadayuki, et al.
Publicado: (2019)

Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report
por: Otsuki, Koji, et al.
Publicado: (2021)

PM351. Efficacy and Safety of Sansoninto for Insomnia in Child and Adolescent Patients: An Open-Label Study
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2016)

Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)
por: Hayashida, Maiko, et al.
Publicado: (2016)

Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy
por: Kanayama, Misako, et al.
Publicado: (2018)

Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat
por: Furuya, Motohide, et al.
Publicado: (2013)

PT596. The comparison with galantamine and donepezil on Alzheimer’s Disease patients and its relationship with cerebral blood flow
por: Wake, Rei, et al.
Publicado: (2016)

Magnetic Resonance Spectroscopy in the Ventral Tegmental Area Distinguishes Responders to Suvorexant Prior to Treatment: A 4-Week Prospective Cohort Study
por: Izuhara, Muneto, et al.
Publicado: (2021)

Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia
por: Kanayama, Misako, et al.
Publicado: (2019)

Contribution of “Genuine Microglia” to Alzheimer's Disease Pathology
por: Hashioka, Sadayuki, et al.
Publicado: (2022)

Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2012)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2015)

Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model
por: Liaury, Kristian, et al.
Publicado: (2012)

May Salivary Alpha-Amylase Level Be a Useful Tool for Assessment of the Severity of Schizophrenia and Evaluation of Therapy? A Case Report
por: Ieda, Masa, et al.
Publicado: (2012)

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease
por: Hashioka, Sadayuki, et al.
Publicado: (2021)

Do Alzheimer's Disease Risk Gene Products Actually Act in Microglia?
por: Hashioka, Sadayuki, et al.
Publicado: (2020)

Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis
por: Fujioka, Mao, et al.
Publicado: (2020)

Social cognition in patients with first episode of psychosis in remission
por: Sen, Mahadev Singh, et al.
Publicado: (2020)

Achievement of remission after first-episode psychosis in youth
por: Kaleda, V., et al.
Publicado: (2021)

Relationship between COVID-19-specific occupational stressors and mental distress in frontline and non-frontline staff
por: Hazumi, Megumi, et al.
Publicado: (2022)

Different trajectories of the first-episode psychosis remission in young adults
por: Kaleda, V., et al.
Publicado: (2022)

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
por: Ottesen, Akiah, et al.
Publicado: (2023)

T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Worthington, Michelle, et al.
Publicado: (2020)

Symptomatic Remission Along the Clinical Psychosis Spectrum: A Historical and Conceptual Review
por: BİNBAY, Tolga, et al.
Publicado: (2021)

Molecular remission at T cell level in patients with rheumatoid arthritis
por: Inamo, Jun, et al.
Publicado: (2021)

Can cognitive insight predict symptom remission in a first episode psychosis cohort?
por: O’Connor, Jennifer A., et al.
Publicado: (2017)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis
por: Catalan, Ana, et al.
Publicado: (2021)

Evaluation of the difference-correction effect of the gamma camera systems used by easy Z-score Imaging System (eZIS) analysis
por: Yamamoto, Yasushi, et al.
Publicado: (2014)

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3qlevmb0qtimguk0ab0kdiaf1